½ÃÀ庸°í¼­
»óǰÄÚµå
1493241

¼¼°èÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2024-2030³â)

Electroencephalography Devices Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³úÆÄ °Ë»ç±â±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 23¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2024³âºÎÅÍ 2030³â±îÁöÀÇ CAGRÀº 10.36%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °£Áú, ¼ö¸éÀå¾Ö, ³úÁ¾¾ç, ÆÄŲ½¼º´, ³úÁ¹Áß µî ½Å°æÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁ® ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 5,000¸¸ ¸í ÀÌ»óÀÌ °£ÁúÀ» ¾Î°í ÀÖÀ¸¸ç, ¼¼°è 3,560¸¸ ¸í ÀÌ»óÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´°ú Ä¡¸Å·Î °íÅë¹Þ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ¼±Áø±¹°ú ½ÅÈï±¹ ½ÃÀå¿¡¼­´Â ½Å°æÁúȯ°ú ½Å°æÀå¾Ö¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ½ÃÀå È®´ë°¡ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½Å°æ°úÇÐ °ü·Ã ¿¬±¸°³¹ß¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±Þ¼ÓÈ÷ ¹ßÀüÇÏ´Â °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ¾Æ½Ã¾Æ ±¹°¡ÀÇ °¡Ã³ºÐ ¼Òµæ Áõ°¡°¡ ÷´Ü ³úÆÄ°è(EEG) Àåºñ ¹× ½Ã½ºÅÛ ¼ö¿ä¸¦ Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ÈÞ´ë¿ë ³úÆÄ ½Ã½ºÅÛ°ú °°Àº ±â¼úÀûÀ¸·Î °í±Þ Á¦Ç°ÀÇ µµÀÔÀÌ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æ°úÇÐ, ÀÎÁö½É¸®ÇÐ ¹× ½É¸®»ý¸®ÇÐÀû ¿¬±¸ Ȱµ¿¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ÷´Ü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

³úÆÄ °Ë»ç±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • 32ä³Î EEG ½Ã½ºÅÛÀº 32ä³Î EEG Á¦Ç°ÀÇ °ßÁ¶ÇÑ ±â¼ú Áøº¸·Î ÀÎÇØ 2023³â¿¡ °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÏ´Â ºÎ¹®ÀÌ¿´½À´Ï´Ù.
  • 2023³â¿¡´Â º´¿ø ¹× Áø´Ü¼¾ÅÍ¿¡¼­ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ÀÀ¿ëÀÌ Áõ°¡ÇÏ¿© µ¶¸³Çü ÀåÄ¡°¡ °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÏ´Â ºÎ¹®À» Â÷ÁöÇß½À´Ï´Ù.
  • º´¿ø ºÎ¹®Àº ½Å°æº´ÁõÀ» ¾Î°í Àִ ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó 2023³â ÃÖÁ¾ ¿ëµµ ±âÁØÀ¸·Î ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡µµÀÌ ºÎ¹® ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
  • ºÏ¹Ì´Â 2023³â EEG ½Ã½ºÅÛ/ÀåÄ¡ ½ÃÀå¿¡¼­ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ³ú ¸ð´ÏÅ͸µÀÇ º¸Çè Àû¿ëÀÌ °¡´ÉÇÏ°í °Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ ¹ß´ÞÇϰí ÀÖ´Ù´Â °ÍÀÌ ÀÌ Áö¿ª ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ³úÆÄ °Ë»ç±â±â ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ³úÆÄ °Ë»ç±â±â ½ÃÀå : Á¦Ç° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : Á¦Ç°º° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • 8ä³Î EEG
  • 21ä³Î EEG
  • 25ä³Î EEG
  • 32ä³Î EEG
  • 40ä³Î EEG
  • ¸ÖƼä³Î EEG

Á¦5Àå ³úÆÄ °Ë»ç±â±â ½ÃÀå : À¯Çü ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : º¯µ¿ ºÐ¼® À¯Çü
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : À¯Çüº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • µ¶¸³Çü µð¹ÙÀ̽º
  • ÈÞ´ë¿ë ÀåÄ¡
  • ¿þ¾î·¯ºí µð¹ÙÀ̽º

Á¦6Àå ³úÆÄ °Ë»ç±â±â ½ÃÀå : ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : ¿ëµµº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ¿Ü»ó°ú ¼ö¼ú
  • Áúº´ Áø´Ü
  • ¸¶Ãë ¸ð´ÏÅ͸µ
  • ¼ö¸é ¸ð´ÏÅ͸µ
  • ±âŸ

Á¦7Àå ³úÆÄ °Ë»ç±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ º¯µ¿ ºÐ¼®
  • ³úÆÄ °Ë»ç±â±â ½ÃÀåÀÇ ÃÖÁ¾ ¿ëµµº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • º´¿ø
  • Áø´Ü¼¾ÅÍ
  • ±âŸ

Á¦8Àå ³úÆÄ °Ë»ç±â±â ½ÃÀå :Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • Áö¿ªº° ³úÆÄ °Ë»ç±â±â ½ÃÀå º¯µ¿ ºÐ¼®
  • ³úÆÄ °Ë»ç±â±â ½ÃÀå : Á¦Ç°, À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµº° Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
    • À¯·´
    • À¯·´ÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³úÆÄ °Ë»ç±â±â ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Natus Medical, Inc.
    • Medtronic
    • Nihon Kohden America, Inc.
    • Brain Products GmbH
    • Neurosoft
    • Compumedics Ltd.
    • Electrical Geodesics, Inc.
    • ANT Neuro
    • Lifelines neuro
    • Mitsar
    • Micromed
    • Cadwell Laboratories, Inc.
    • EBNeuro
    • Magstim EGI
    • Emotiv
JHS 24.06.20

Electroencephalography Devices Market Growth & Trends:

The global electroencephalography devices market size is expected to reach a value of USD 2.39 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 10.36% from 2024 to 2030. The high prevalence of epilepsy, sleeping disorders, brain tumors, Parkinson's disease, and stroke among other neurological disorders is a major factor anticipated to drive the growth. According to the World Health Organization (WHO), over 50 million people are affected by epilepsy; and more than 35.6 million people worldwide are suffering from Alzheimer's disease and dementia.

In addition, growing awareness about neurological diseases and disorders in developed and developing regions is expected to boost the market. In addition, a rise in government funding for neuroscience-related R&D is contributing to market growth to a great extent. Moreover, rapidly developing healthcare infrastructure and increasing disposable income in Asian countries are projected to support the demand for advanced electroencephalography (EEG) devices and systems.

Furthermore, the introduction of technologically advanced products such as portable electroencephalography systems is expected to drive the market. Increasing focus on neuroscience, cognitive psychology, and psychophysiological research activities has led to increased demand for advanced systems.

Electroencephalography Devices Market Report Highlights:

  • 32-channel EEG systems remained the highest revenue-generating segment in 2023 attributed to robust technological advancements in 32-channel EEG products
  • In 2023, standalone devices accounted for the highest revenue-generating segment due to the increased application of these systems in hospitals and diagnostics centers
  • The hospitals segment held the largest revenue share based on end-use in 2023, owing to the increasing number of patients suffering from neurological disorders. The rising geriatric population is another major factor responsible for the segment growth
  • North America held the largest revenue share of the EEG system/device market in 2023. The availability of insurance coverage for brain monitoring and well-developed healthcare infrastructure is anticipated to drive the regional demand

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Electroencephalography Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of neurological diseases
      • 3.2.1.2. Rising geriatric population Need to develop technologically advanced diagnostic systems
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of Skilled Radiation Technicians
  • 3.3. Electroencephalography Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Electroencephalography Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Electroencephalography Devices Market: Product Movement Analysis
  • 4.3. Electroencephalography Devices Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. 8-channel EEG
    • 4.5.1. 8-channel EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. 21-channel EEG
    • 4.6.1. 21-channel EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. 25-channel EEG
    • 4.7.1. 25-channel EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. 32-channel EEG
    • 4.8.1. 32-channel EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. 40-channel EEG
    • 4.9.1. 40-channel EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Multichannel EEG
    • 4.10.1. Multichannel EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Electroencephalography Devices Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Electroencephalography Devices Market: Type Movement Analysis
  • 5.3. Electroencephalography Devices Market by Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Standalone Devices
    • 5.5.1. Standalone devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Portable Devices
    • 5.6.1. Portable devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Wearable Devices
    • 5.7.1. Wearable devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Electroencephalography Devices Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Electroencephalography Devices Market: Application Movement Analysis
  • 6.3. Electroencephalography Devices Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Trauma & Surgery
    • 6.5.1. Trauma & Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Disease Diagnosis
    • 6.6.1. Disease Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Anesthesia Monitoring
    • 6.7.1. Anesthesia Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Sleep Monitoring
    • 6.8.1. Sleep Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Electroencephalography Devices Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Electroencephalography Devices Market: End-use Movement Analysis
  • 7.3. Electroencephalography Devices Market by End-use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Diagnostic Centers
    • 7.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Electroencephalography Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Electroencephalography Devices Market movement analysis
  • 8.3. Electroencephalography Devices Market: Regional Estimates & Trend Analysis by Product, Type, Application, & End-use
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. North America
    • 8.5.1. North America Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. U.S. Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Canada Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. Europe
    • 8.5.5. Europe Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. UK
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. UK Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Germany
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Germany Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. France
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. France Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Italy
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement scenario
      • 8.5.9.5. Italy Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.10. Spain
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Framework
      • 8.5.10.4. Reimbursement scenario
      • 8.5.10.5. Spain Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.11. Denmark
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Framework
      • 8.5.11.4. Reimbursement scenario
      • 8.5.11.5. Denmark Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.12. Sweden
      • 8.5.12.1. Key Country Dynamics
      • 8.5.12.2. Competitive Scenario
      • 8.5.12.3. Regulatory Framework
      • 8.5.12.4. Reimbursement scenario
      • 8.5.12.5. Sweden Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.13. Norway
      • 8.5.13.1. Key Country Dynamics
      • 8.5.13.2. Competitive Scenario
      • 8.5.13.3. Regulatory Framework
      • 8.5.13.4. Reimbursement scenario
      • 8.5.13.5. Norway Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Japan Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. China Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. India Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement scenario
      • 8.6.6.5. Australia Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement scenario
      • 8.6.7.5. Thailand Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Brazil Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Mexico Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Argentina
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. Argentina Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. South Africa Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. Saudi Arabia Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. UAE Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement scenario
      • 8.8.5.5. Kuwait Electroencephalography Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Natus Medical, Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Medtronic
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Nihon Kohden America, Inc.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Brain Products GmbH
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Neurosoft
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Compumedics Ltd.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Electrical Geodesics, Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. ANT Neuro
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Lifelines neuro
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Mitsar
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Micromed
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Cadwell Laboratories, Inc.
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. EBNeuro
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. Magstim EGI
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Product benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. Emotiv
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Product benchmarking
      • 9.2.15.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦